Investitionsthese
MHV invests in UK-based health tech founders, enabling domestic growth in the UK while accelerating expansion into the US. The fund partners with NHS trusts and health systems to generate real-world evidence, facilitating broader adoption of portfolio solutions. Their value-added model aligns founders, patients, clinicians, and health systems from the outset.
Investitionsphase
Adoption and scale (transatlantic growth)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Clinical innovators and transformative health tech solutions
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€4.130.000 - €7.350.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (11)
A
Aditi Babel
Associate, Innovations in Mental Health
D
Daniel Dickens
Co-Managing Partner
D
Dr. Aditi Babel
Associate, Innovations in Mental Health
D
Dr. Nadine Haram
Co-Managing Partner
D
Dr. Patrik Bächtiger
Venture Partner, Meridian Health Ventures I
D
Dr. Pooja Sikka
General Partner
M
Madhav Mahendra
Principal, Meridian Health Ventures I
N
Nadine Haram
Co-Managing Partner
P
Patrik Bächtiger
Venture Partner, Meridian Health Ventures I
P
Pooja Sikka
General Partner
T
Tim Irish
General Partner